cerrar
Tagged with access,

Interview: Vivek Kamath – Managing Director, MSD India
A strong supporter of public-private partnerships, MSD’s managing director in India, Vivek Kamath, explains how the company’s collaborative…

Interview: Jawed Zia – Country President, Novartis India
Think global, act local! This is the Novartis business approach in India. A great believer in stakeholder collaboration, Jawed Zia, country president…

Interview: Kadri Mägi-Lehtsi – General Manager, Roche…
Kadri Maegi-Lehtsi, general manager of Roche Pharmaceuticals Estonia, discusses the company’s established footprint in the Estonian market and their…

Interview: Kuuno Vaher – Market Access Director Baltics and…
Kuuno Vaher, market access director Baltics and country lead of AstraZeneca Estonia, discusses the liberal attitude towards innovative and highly…

Interview: Artur Chabowski – President of Mabion, Poland
Artur Chabowski, president of Mabion, a pioneer Polish biotech player, discusses the historic partnership of their product, MabionCD20 with Mylan for…

Aki Kasvi – General Manager; Mindaugas Plieskis – Head of…
Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring…

Interview: Joanna Drewla – General Manager, Servier Poland
Joanna Drewla, general manager of Servier Poland, discusses Polish healthcare challenges and looks at areas for improvement to create a sustainable…

Interview: Ken Spears – Vice President & General…
Boston Scientific’s vice president and general manager Ken Spears shares his thoughts about the potential for Canada to become an early adopter of…

Interview: Svens Henkuzens – Director, State Agency of…
Svens Henkuzens, director of the State Agency of Medicines in Latvia discusses the key role of the organization in the country and the objectives he…

Interview: Dorota Hryniewiecka-Firlej – President, Pfizer…
Dorota Hryniewiecka-Firlej, president of Pfizer Poland, discusses the current state of the Polish innovation landscape and importance of a tight-knit…

Market Access in Serbia: Steps in the Right Direction
Between 2010 and 2012 just one of the 139 new medicines to receive market authorisations globally was approved for reimbursement in Serbia, compared…

Interview: Iwona Skrzekowska-Baran – Owner & CEO,…
Iwona Skrzekowska-Baran, owner and CEO of Pharm&Med, a young, exciting Polish consultancy that is helping clients to transform evidence, policy…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here